In Part II of this blog series we look at recent transactions in the arena of contract research organization, with a particular focus on private equity investing in CROs.

In one recent example, prescription drug data-mining company IMS Health acquired

Continue Reading Private Equity Opportunities in Contract Research Organizations (CROs): Part II

Contract research organizations (CRO) provide research services support for the biotechnology, medical device and pharmaceutical industries on a contractual basis. They offer such services as preclinical and clinical research, clinical trials management, biopharmaceutical development and pharmacovigilance. CROs run the gamut

Continue Reading Private Equity Opportunities in Contract Research Organizations (CROs): Part I

PPD/Pharmaceutical Product Development, an international contract research firm that has just been named to the 2011 InformationWeek 500, is being taken private by affiliates of the Carlyle Group and Hellman & Friedman in a cash deal valued at

Continue Reading Contract Research Organizations (CROs) Go Private; Another Segment of Opportunity for Investors?